{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T09:41:57Z","timestamp":1777282917208,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,27]]},"DOI":"10.7759\/cureus.107785","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T08:51:22Z","timestamp":1777279882000},"source":"Crossref","is-referenced-by-count":0,"title":["Fibrosis-4 (FIB-4) Index Is Associated With Skeletal Muscle Mass in Japanese Patients With Type 2 Diabetes: A Single-Center Retrospective Cross-Sectional Study"],"prefix":"10.7759","author":[{"given":"Hiroyuki","family":"Ito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chizuko","family":"Yukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiaki","family":"I","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzuko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Antoku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayuri","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2537","article-title":"Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study","volume":"30","author":"Park SW","year":"2007","unstructured":"Park SW, Goodpaster BH, Strotmeyer ES, et al.. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007, 30:1507-12. 10.2337\/dc06-2537","journal-title":"Diabetes Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1375610","article-title":"Type 2 diabetes mellitus related sarcopenia: a type of muscle loss distinct from sarcopenia and disuse muscle atrophy","volume":"15","author":"Liu Z","year":"2024","unstructured":"Liu Z, Guo Y, Zheng C. Type 2 diabetes mellitus related sarcopenia: a type of muscle loss distinct from sarcopenia and disuse muscle atrophy. Front Endocrinol (Lausanne). 2024, 15:1375610. 10.3389\/fendo.2024.1375610","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/nu15234955","article-title":"Association of a combination of sarcopenia and type 2 diabetes with blood parameters, nutrient intake, and physical activity: a nationwide population-based study","volume":"15","author":"Kim M","year":"2023","unstructured":"Kim M, Kobori T. Association of a combination of sarcopenia and type 2 diabetes with blood parameters, nutrient intake, and physical activity: a nationwide population-based study. Nutrients. 2023, 15:4955. 10.3390\/nu15234955","journal-title":"Nutrients"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2017.12.011","article-title":"The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus","volume":"109","author":"Sarodnik C","year":"2018","unstructured":"Sarodnik C, Bours SP, Schaper NC, van den Bergh JP, van Geel TA. The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus. Maturitas. 2018, 109:70-7. 10.1016\/j.maturitas.2017.12.011","journal-title":"Maturitas"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glab062","article-title":"Risk factors for incident falls and fractures in older men with and without type 2 diabetes mellitus: the Concord Health and Ageing in Men Project","volume":"76","author":"Mesinovic J","year":"2021","unstructured":"Mesinovic J, Scott D, Seibel MJ, et al.. Risk factors for incident falls and fractures in older men with and without type 2 diabetes mellitus: the Concord Health and Ageing in Men Project. J Gerontol A Biol Sci Med Sci. 2021, 76:1090-100. 10.1093\/gerona\/glab062","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175499","article-title":"Sarcopenia in type 2 diabetes mellitus: study of the modifiable risk factors involved","volume":"12","author":"Sravya SL","year":"2023","unstructured":"Sravya SL, Swain J, Sahoo AK, Mangaraj S, Kanwar J, Jadhao P, Das S. Sarcopenia in type 2 diabetes mellitus: study of the modifiable risk factors involved\r\n. J Clin Med. 2023, 12:5499. 10.3390\/jcm12175499","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.782391","article-title":"The association between diabetes mellitus and risk of sarcopenia: accumulated evidences from observational studies","volume":"12","author":"Qiao YS","year":"2021","unstructured":"Qiao YS, Chai YH, Gong HJ, Zhuldyz Z, Stehouwer CD, Zhou JB, Sim\u00f3 R. The association between diabetes mellitus and risk of sarcopenia: accumulated evidences from observational studies. Front Endocrinol (Lausanne). 2021, 12:782391. 10.3389\/fendo.2021.782391","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.111063","article-title":"Prolonged hospitalization and 1-year mortality are associated with sarcopenia and malnutrition in older patients with type 2 diabetes: a prospective cohort study","volume":"207","author":"Beretta MV","year":"2024","unstructured":"Beretta MV, de Paula TP, da Costa Rodrigues T, Steemburgo T. Prolonged hospitalization and 1-year mortality are associated with sarcopenia and malnutrition in older patients with type 2 diabetes: a prospective cohort study. Diabetes Res Clin Pract. 2024, 207:111063. 10.1016\/j.diabres.2023.111063","journal-title":"Diabetes Res Clin Pract"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.783363","article-title":"Sarcopenia is associated with a risk of mortality in people with type 2 diabetes mellitus","volume":"12","author":"Takahashi F","year":"2021","unstructured":"Takahashi F, Hashimoto Y, Kaji A, et al.. Sarcopenia is associated with a risk of mortality in people with type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2021, 12:783363. 10.3389\/fendo.2021.783363","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S410834","article-title":"The association between sarcopenia and diabetes: from pathophysiology mechanism to therapeutic strategy","volume":"16","author":"Chen H","year":"2023","unstructured":"Chen H, Huang X, Dong M, Wen S, Zhou L, Yuan X. The association between sarcopenia and diabetes: from pathophysiology mechanism to therapeutic strategy. Diabetes Metab Syndr Obes. 2023, 16:1541-54. 10.2147\/DMSO.S410834","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S004","article-title":"4: Comprehensive medical evaluation and assessment of comorbidities: Standards of Care in Diabetes-2025","volume":"48","year":"2025","unstructured":"4. Comprehensive medical evaluation and assessment of comorbidities: Standards of Care in Diabetes-2025. Diabetes Care. 2025, 48:S59-85. 10.2337\/dc25-S004","journal-title":"Diabetes Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1294267","article-title":"Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic","volume":"10","author":"Rao G","year":"2023","unstructured":"Rao G, Peng X, Li X, et al.. Unmasking the enigma of lipid metabolism in metabolic dysfunction-associated steatotic liver disease: from mechanism to the clinic. Front Med (Lausanne). 2023, 10:1294267. 10.3389\/fmed.2023.1294267","journal-title":"Front Med (Lausanne)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling RK","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al.. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006, 43:1317-25. 10.1002\/hep.21178","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v16.i6.871","article-title":"Sarcopenia and metabolic dysfunction associated steatotic liver disease: time to address both","volume":"16","author":"Wong R","year":"2024","unstructured":"Wong R, Yuan LY. Sarcopenia and metabolic dysfunction associated steatotic liver disease: time to address both. World J Hepatol. 2024, 16:871-7. 10.4254\/wjh.v16.i6.871","journal-title":"World J Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32049","article-title":"Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"Lai JC","year":"2021","unstructured":"Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2021, 74:1611-44. 10.1002\/hep.32049","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2022.114581","article-title":"Sarcopenia in liver cirrhosis: prevalence, pathophysiology and therapeutic strategies","volume":"647","author":"Fox R","year":"2022","unstructured":"Fox R, Stenning K, Slee A, Macnaughtan J, Davies N. Sarcopenia in liver cirrhosis: prevalence, pathophysiology and therapeutic strategies. Anal Biochem. 2022, 647:114581. 10.1016\/j.ab.2022.114581","journal-title":"Anal Biochem"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2023.11.008","article-title":"Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"43","author":"Tuo S","year":"2024","unstructured":"Tuo S, Yeo YH, Chang R, et al.. Prevalence of and associated factors for sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis. Clin Nutr. 2024, 43:84-94. 10.1016\/j.clnu.2023.11.008","journal-title":"Clin Nutr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-024-03709-1","article-title":"Comparative analysis of sarcopenia in hospitalized elderly: exploring the impact of liver cirrhosis","volume":"19","author":"Romano AD","year":"2024","unstructured":"Romano AD, Cornacchia MG, Sangineto M, Di Gioia G, Villani R, Serviddio G. Comparative analysis of sarcopenia in hospitalized elderly: exploring the impact of liver cirrhosis. Intern Emerg Med. 2024, 19:1949-57. 10.1007\/s11739-024-03709-1","journal-title":"Intern Emerg Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.5250-25","article-title":"Impact of the FIB4 index on pre-sarcopenia in patients with metabolic-dysfunction associated steatotic liver disease","volume":"64","author":"Nishikawa H","year":"2025","unstructured":"Nishikawa H, Nishikawa T, Fukuda A, et al.. Impact of the FIB4 index on pre-sarcopenia in patients with metabolic-dysfunction associated steatotic liver disease. Intern Med. 2025, 64:3078-87. 10.2169\/internalmedicine.5250-25","journal-title":"Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-021-01902-2","article-title":"Excessive alcohol intake and liver fibrosis are associated with skeletal muscle mass reduction in elderly men: the Wakayama study","volume":"34","author":"Onishi S","year":"2022","unstructured":"Onishi S, Miyai N, Zhang Y, Oka T, Nogami E, Utsumi M, Arita M. Excessive alcohol intake and liver fibrosis are associated with skeletal muscle mass reduction in elderly men: the Wakayama study. Aging Clin Exp Res. 2022, 34:185-92. 10.1007\/s40520-021-01902-2","journal-title":"Aging Clin Exp Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5009\/gnl19126","article-title":"Sarcopenia is independently associated with the degree of liver fibrosis in patients with type 2 diabetes mellitus","volume":"14","author":"Sung MJ","year":"2020","unstructured":"Sung MJ, Lim TS, Jeon MY, et al.. Sarcopenia is independently associated with the degree of liver fibrosis in patients with type 2 diabetes mellitus. Gut Liver. 2020, 14:626-35. 10.5009\/gnl19126","journal-title":"Gut Liver"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15595","article-title":"Low skeletal muscle mass is associated with liver fibrosis in individuals with type 2 diabetes and nonalcoholic fatty liver disease","volume":"36","author":"Kuchay MS","year":"2021","unstructured":"Kuchay MS, Choudhary NS, Gagneja S, et al.. Low skeletal muscle mass is associated with liver fibrosis in individuals with type 2 diabetes and nonalcoholic fatty liver disease. J Gastroenterol Hepatol. 2021, 36:3204-11. 10.1111\/jgh.15595","journal-title":"J Gastroenterol Hepatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen LK","year":"2020","unstructured":"Chen LK, Woo J, Assantachai P, et al.. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020, 21:300-7.e2. 10.1016\/j.jamda.2019.12.012","journal-title":"J Am Med Dir Assoc"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, et al.. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007, 370:1453-7. 10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-020-00453-7","article-title":"FIB-4 index-based surveillance for advanced liver fibrosis in diabetes patients","volume":"12","author":"Kawata N","year":"2021","unstructured":"Kawata N, Takahashi H, Iwane S, et al.. FIB-4 index-based surveillance for advanced liver fibrosis in diabetes patients. Diabetol Int. 2021, 12:118-25. 10.1007\/s13340-020-00453-7","journal-title":"Diabetol Int"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-022-02575-5","article-title":"Hypertension and diabetes mellitus are associated with high FIB-4 index in a health checkup examination cohort without known liver disease","volume":"22","author":"Sato S","year":"2022","unstructured":"Sato S, Kawai H, Sato S, et al.. Hypertension and diabetes mellitus are associated with high FIB-4 index in a health checkup examination cohort without known liver disease. BMC Gastroenterol. 2022, 22:478. 10.1186\/s12876-022-02575-5","journal-title":"BMC Gastroenterol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella ME","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, et al.. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023, 79:1542-56. 10.1016\/j.jhep.2023.06.003","journal-title":"J Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2486\/indhealth.2023-0182","article-title":"A longitudinal study of the influence of work characteristics, work-family status, and social activities on problem drinking: the Japanese civil servants study","volume":"62","author":"Shigeno T","year":"2024","unstructured":"Shigeno T, Tatsuse T, Sekine M, Yamada M. A longitudinal study of the influence of work characteristics, work-family status, and social activities on problem drinking: the Japanese civil servants study. Ind Health. 2024, 62:417-28. 10.2486\/indhealth.2023-0182","journal-title":"Ind Health"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20160200","article-title":"Impact of alcohol intake and drinking patterns on mortality from all causes and major causes of death in a Japanese population","volume":"28","author":"Saito E","year":"2018","unstructured":"Saito E, Inoue M, Sawada N, et al.. Impact of alcohol intake and drinking patterns on mortality from all causes and major causes of death in a Japanese population. J Epidemiol. 2018, 28:140-8. 10.2188\/jea.JE20160200","journal-title":"J Epidemiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001629","article-title":"Effect of alcohol consumption and the presence of fatty liver on the risk for incident type 2 diabetes: a population-based longitudinal study","volume":"8","author":"Okamura T","year":"2020","unstructured":"Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Effect of alcohol consumption and the presence of fatty liver on the risk for incident type 2 diabetes: a population-based longitudinal study. BMJ Open Diabetes Res Care. 2020, 8:e001629. 10.1136\/bmjdrc-2020-001629","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2007.01.053","article-title":"Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy","volume":"77","author":"Yasuda H","year":"2007","unstructured":"Yasuda H, Sanada M, Kitada K, et al.. Rationale and usefulness of newly devised abbreviated diagnostic criteria and staging for diabetic polyneuropathy. Diabetes Res Clin Pract. 2007, 77:S178-83. 10.1016\/j.diabres.2007.01.053","journal-title":"Diabetes Res Clin Pract"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.31662\/jmaj.2025-0071","article-title":"Phase angle evaluated by a bioimpedance analysis is closely related to diabetic nephropathy and peripheral neuropathy in patients with type 2 diabetes","volume":"8","author":"Ito H","year":"2025","unstructured":"Ito H, Miura S, Mori T, et al.. Phase angle evaluated by a bioimpedance analysis is closely related to diabetic nephropathy and peripheral neuropathy in patients with type 2 diabetes. JMA J. 2025, 8:925-35. 10.31662\/jmaj.2025-0071","journal-title":"JMA J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.14002","article-title":"The change in Fibrosis-4 index in Japanese patients with type\u00a02 diabetes treated by a fixed-ratio combination therapy of insulin degludec and liraglutide: a retrospective observational study","volume":"54","author":"Ito H","year":"2024","unstructured":"Ito H, Someya R, Ando S, et al.. The change in Fibrosis-4 index in Japanese patients with type\u00a02 diabetes treated by a fixed-ratio combination therapy of insulin degludec and liraglutide: a retrospective observational study. Hepatol Res. 2024, 54:513-24. 10.1111\/hepr.14002","journal-title":"Hepatol Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.70032","article-title":"Effect of luseogliflozin on liver fibrosis differs depending on alcohol consumption in patients with type 2 diabetes","volume":"16","author":"Ito H","year":"2025","unstructured":"Ito H, Someya R, Koyanagi T, et al.. Effect of luseogliflozin on liver fibrosis differs depending on alcohol consumption in patients with type 2 diabetes. J Diabetes Investig. 2025, 16:1001-9. 10.1111\/jdi.70032","journal-title":"J Diabetes Investig"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-2049","article-title":"Comparison of tofogliflozin and glimepiride effects on nonalcoholic fatty liver disease in participants with type 2 diabetes: a randomized, 48-week, open-label, active-controlled trial","volume":"45","author":"Takeshita Y","year":"2022","unstructured":"Takeshita Y, Honda M, Harada K, et al.. Comparison of tofogliflozin and glimepiride effects on nonalcoholic fatty liver disease in participants with type 2 diabetes: a randomized, 48-week, open-label, active-controlled trial. Diabetes Care. 2022, 45:2064-75. 10.2337\/dc21-2049","journal-title":"Diabetes Care"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14799","article-title":"Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: a real-world data analysis","volume":"41","author":"Colosimo S","year":"2021","unstructured":"Colosimo S, Ravaioli F, Petroni ML, et al.. Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: a real-world data analysis. Liver Int. 2021, 41:731-42. 10.1111\/liv.14799","journal-title":"Liver Int"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1203666","article-title":"Effect of sodium-glucose transporter 2 inhibitors on sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"14","author":"Zhang S","year":"2023","unstructured":"Zhang S, Qi Z, Wang Y, Song D, Zhu D. Effect of sodium-glucose transporter 2 inhibitors on sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023, 14:1203666. 10.3389\/fendo.2023.1203666","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15728","article-title":"Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies","volume":"26","author":"Neeland IJ","year":"2024","unstructured":"Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes Obes Metab. 2024, 26:16-27. 10.1111\/dom.15728","journal-title":"Diabetes Obes Metab"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91101-0","article-title":"Longitudinal association of SGLT2 inhibitors and GLP-1RAs on falls in persons with type 2 diabetes","volume":"15","author":"Suzuki Y","year":"2025","unstructured":"Suzuki Y, Suzuki H, Maruo K, et al.. Longitudinal association of SGLT2 inhibitors and GLP-1RAs on falls in persons with type 2 diabetes. Sci Rep. 2025, 15:9178. 10.1038\/s41598-025-91101-0","journal-title":"Sci Rep"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2019.10.004","article-title":"Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes","volume":"46","author":"Seo DH","year":"2020","unstructured":"Seo DH, Lee YH, Park SW, et al.. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes. Diabetes Metab. 2020, 46:362-9. 10.1016\/j.diabet.2019.10.004","journal-title":"Diabetes Metab"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11020243","article-title":"The association between non-alcoholic fatty liver disease and dynapenia in men diagnosed with type 2 diabetes mellitus","volume":"11","author":"Bulur A","year":"2023","unstructured":"Bulur A, Sivritepe R. The association between non-alcoholic fatty liver disease and dynapenia in men diagnosed with type 2 diabetes mellitus. Healthcare (Basel). 2023, 11:243. 10.3390\/healthcare11020243","journal-title":"Healthcare (Basel)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.453","article-title":"Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis","volume":"112","author":"McPherson S","year":"2017","unstructured":"McPherson S, Hardy T, Dufour JF, et al.. Age as a confounding factor for the accurate non-invasive diagnosis of advanced NAFLD fibrosis. Am J Gastroenterol. 2017, 112:740-51. 10.1038\/ajg.2016.453","journal-title":"Am J Gastroenterol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.14462","article-title":"Association between diabetic peripheral neuropathy and sarcopenia: a systematic review and meta-analysis","volume":"22","author":"Wannarong T","year":"2022","unstructured":"Wannarong T, Sukpornchairak P, Naweera W, Geiger CD, Ungprasert P. Association between diabetic peripheral neuropathy and sarcopenia: a systematic review and meta-analysis. Geriatr Gerontol Int. 2022, 22:785-9. 10.1111\/ggi.14462","journal-title":"Geriatr Gerontol Int"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108096","article-title":"Association of sarcopenia and muscle mass with both peripheral neuropathy and nerve function in patients with type 2 diabetes","volume":"162","author":"Zhang Y","year":"2020","unstructured":"Zhang Y, Shen X, He L, Zhao F, Yan S. Association of sarcopenia and muscle mass with both peripheral neuropathy and nerve function in patients with type 2 diabetes. Diabetes Res Clin Pract. 2020, 162:108096. 10.1016\/j.diabres.2020.108096","journal-title":"Diabetes Res Clin Pract"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13788","article-title":"Association between sarcopenia and the severity of diabetic polyneuropathy assessed by nerve conduction studies in Japanese patients with type\u20092 diabetes mellitus","volume":"13","author":"Mikura K","year":"2022","unstructured":"Mikura K, Kodama E, Iida T, et al.. Association between sarcopenia and the severity of diabetic polyneuropathy assessed by nerve conduction studies in Japanese patients with type\u20092 diabetes mellitus. J Diabetes Investig. 2022, 13:1357-65. 10.1111\/jdi.13788","journal-title":"J Diabetes Investig"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0435","article-title":"Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey","volume":"96","author":"Srikanthan P","year":"2011","unstructured":"Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab. 2011, 96:2898-903. 10.1210\/jc.2011-0435","journal-title":"J Clin Endocrinol Metab"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.08.019","article-title":"Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis","volume":"66","author":"Koo BK","year":"2017","unstructured":"Koo BK, Kim D, Joo SK, et al.. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol. 2017, 66:123-31. 10.1016\/j.jhep.2016.08.019","journal-title":"J Hepatol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26716","article-title":"Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study","volume":"59","author":"Hong HC","year":"2014","unstructured":"Hong HC, Hwang SY, Choi HY, et al.. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study. Hepatology. 2014, 59:1772-8. 10.1002\/hep.26716","journal-title":"Hepatology"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.05.016","article-title":"Treatment of NAFLD with diet, physical activity and exercise","volume":"67","author":"Romero-G\u00f3mez M","year":"2017","unstructured":"Romero-G\u00f3mez M, Zelber-Sagi S, Trenell M. Treatment of NAFLD with diet, physical activity and exercise. J Hepatol. 2017, 67:829-46. 10.1016\/j.jhep.2017.05.016","journal-title":"J Hepatol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.maturitas.2016.11.006","article-title":"Inflammation and sarcopenia: a systematic review and meta-analysis","volume":"96","author":"Bano G","year":"2017","unstructured":"Bano G, Trevisan C, Carraro S, et al.. Inflammation and sarcopenia: a systematic review and meta-analysis. Maturitas. 2017, 96:10-5. 10.1016\/j.maturitas.2016.11.006","journal-title":"Maturitas"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12851","article-title":"Sodium-glucose cotransporter 2 inhibitor-induced changes in body composition and simultaneous changes in metabolic profile: 52-week prospective LIGHT (luseogliflozin: the components of weight loss in Japanese patients with type 2 diabetes mellitus) study","volume":"10","author":"Sasaki T","year":"2019","unstructured":"Sasaki T, Sugawara M, Fukuda M. Sodium-glucose cotransporter 2 inhibitor-induced changes in body composition and simultaneous changes in metabolic profile: 52-week prospective LIGHT (luseogliflozin: the components of weight loss in Japanese patients with type 2 diabetes mellitus) study. J Diabetes Investig. 2019, 10:108-17. 10.1111\/jdi.12851","journal-title":"J Diabetes Investig"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding JP","year":"2021","unstructured":"Wilding JP, Batterham RL, Calanna S, et al.. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021, 384:989-1002. 10.1056\/NEJMoa2032183","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/483749-fibrosis-4-fib-4-index-is-associated-with-skeletal-muscle-mass-in-japanese-patients-with-type-2-diabetes-a-single-center-retrospective-cross-sectional-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T08:51:25Z","timestamp":1777279885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/483749-fibrosis-4-fib-4-index-is-associated-with-skeletal-muscle-mass-in-japanese-patients-with-type-2-diabetes-a-single-center-retrospective-cross-sectional-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":52,"URL":"https:\/\/doi.org\/10.7759\/cureus.107785","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}